Drugging the Elusive KRAS
Kevan M. Shokat, PhD, shifted the paradigm of targeted cancer therapy by drugging an “undruggable” protein and paving the way for future advances.
Cancer Talk
Lesbians, bisexual women and transgender men had a longer wait for diagnosis and a higher risk of recurrence.
by Jon Kelvey
Deconstructing Peripheral Neuropathy and Chemo BrainResearchers explore mechanisms of chemotherapy-related neurotoxicity at the AACR Annual Meeting 2023.
by Marci A. Landsmann
AACR Annual Meeting 2023Catch up on all of Cancer Today's coverage from the AACR Annual Meeting 2023.
More Prostate Cancer Patients Choose SurveillanceMen are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
by Kyle Bagenstose
From the AACR
-
The Many Aspects of Early Detection and Interception of Cancer
Early detection is key to improving outcomes from cancer. Research in cancer interception aims to characterize tumors at the earliest stages of development.
-
Translating Personal Tragedy Into the Search for New Cancer Therapeutics
Dr. Patricia LoRusso’s parents both died of cancer when she was a teenager, inspiring her to become an oncologist and develop new treatments for people with cancer.
Video
Bringing Cancer Research to Life: Elizabeth M. Jaffee, MD, FAACR
